CLOXACILLIN FOR INJECTION POWDER FOR SOLUTION

País: Canadà

Idioma: anglès

Font: Health Canada

ingredients actius:

CLOXACILLIN (CLOXACILLIN SODIUM)

Disponible des:

STERIMAX INC

Codi ATC:

J01CF02

Designació comuna internacional (DCI):

CLOXACILLIN

Dosis:

1G

formulario farmacéutico:

POWDER FOR SOLUTION

Composición:

CLOXACILLIN (CLOXACILLIN SODIUM) 1G

Vía de administración:

INTRAVENOUS

Unidades en paquete:

10

tipo de receta:

Prescription

Área terapéutica:

PENICILLINASE-RESISTANT PENICILLINS

Resumen del producto:

Active ingredient group (AIG) number: 0131306009; AHFS:

Estat d'Autorització:

MARKETED

Data d'autorització:

2011-07-28

Fitxa tècnica

1
PRESCRIBING INFORMATION
PR
CLOXACILLIN FOR INJECTION
Cloxacillin Powder for Solution (as cloxacillin sodium)
500mg powder/vial
1g powder/vial
2g powder/vial
10g powder/vial
STERILE
ANTIBIOTIC
SteriMax Inc.
2770 Portland Drive,
Oakville, ON
L6H 6R4
Date of Revision:
February 14, 2019
CONTROL NUMBER: 221983
2
TABLE OF CONTENTS
PART 1: HEALTH PROFESSIONAL INFORMATION
………………………......
3
SUMMARY PRODUCT
INFORMATION……………………………………...
3
INDICATIONS AND CLINICAL
USE…………………………………………
3
CONTRAINDICATIONS……………………………………………………….
3
WARNINGS AND
PRECAUTIONS……………………………………………
4
ADVERSE
REACTIONS………………………………………………………..
5
DRUG
INTERACTIONS………………………………………………………...
5
DOSAGE AND
ADMINISTRATION…………………………………………..
5
OVERDOSAGE………………………………………………………………….
7
ACTIONS AND CLINCAL PHARMACOLOGY………………………………
7
STORAGE AND
STABILITY…………………………………………………...
8
DOSAGE FORMS, COMPOSITION AND PACKAGING……………………..
8
PART II: SCIENTIFIC INFORMATION
...................................................................
9
PHARMACEUTICAL
INFORMATION………………….............…….............
9
PART III: CONSUMER INFORMATION
..................................................................
10
3
PRESCRIBING INFORMATION
PR
CLOXACILLIN FOR INJECTION
CLOXACILLIN POWDER FOR SOLUTION (AS CLOXACILLIN SODIUM)
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF
ADMINISTRATION
DOSAGE FORM /
STRENGTH
CLINICALLY RELEVANT NON-MEDICINAL
INGREDIENTS
IV, IM, IV Infusion
Powder for
reconstitution for
INJECTION
None
INDICATIONS AND CLINICAL USE
The treatment of beta-hemolytic streptococcal and pneumococcal
infections as well as
staphylococcal infections (inc